id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_3300
split_0_train_3300
[ { "id": "split_0_train_3300_passage", "type": "progene_text", "text": [ "Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells : involvement with MHC class I killer cell inhibitory receptors ." ], "offsets": [ [ 0, 197 ] ] } ]
[ { "id": "split_0_train_5336_entity", "type": "progene_text", "text": [ "MHC class I" ], "offsets": [ [ 151, 162 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3301
split_0_train_3301
[ { "id": "split_0_train_3301_passage", "type": "progene_text", "text": [ "The natural killer tumor recognition ( NK-TR ) protein has been shown to be a necessary component for the killing of NK - sensitive and virus - infected targets by the rat RNK-16 cell line ." ], "offsets": [ [ 0, 190 ] ] } ]
[ { "id": "split_0_train_5337_entity", "type": "progene_text", "text": [ "natural killer tumor recognition ( NK-TR ) protein" ], "offsets": [ [ 4, 54 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3302
split_0_train_3302
[ { "id": "split_0_train_3302_passage", "type": "progene_text", "text": [ "Class I-recognizing killer cell inhibitory receptors ( KIR ) have been found in the human ( p58 ; NKAT family ) and mouse ( Ly-49 family ) ." ], "offsets": [ [ 0, 140 ] ] } ]
[ { "id": "split_0_train_5338_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 55, 58 ] ], "normalized": [] }, { "id": "split_0_train_5339_entity", "type": "progene_text", "text": [ "p58" ], "offsets": [ [ 92, 95 ] ], "normalized": [] }, { "id": "split_0_train_5340_entity", "type": "progene_text", "text": [ "NKAT family" ], "offsets": [ [ 98, 109 ] ], "normalized": [] }, { "id": "split_0_train_5341_entity", "type": "progene_text", "text": [ "Ly-49 family" ], "offsets": [ [ 124, 136 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3303
split_0_train_3303
[ { "id": "split_0_train_3303_passage", "type": "progene_text", "text": [ "The principal functional characteristic of these receptors is their ability to block NK cell lysis by recognition of selected class I molecules on target cells ." ], "offsets": [ [ 0, 161 ] ] } ]
[]
[]
[]
[]
split_0_train_3304
split_0_train_3304
[ { "id": "split_0_train_3304_passage", "type": "progene_text", "text": [ "In the present study , we examined whether abrogation of NK-TR expression by retroviral infection of primary human or mouse NK cells with virus - producing antisense NK-TR also would demonstrate loss of non - MHC - restricted killing and whether the NK-TR was associated with KIR function in humans or with Ly-49 in the mouse ." ], "offsets": [ [ 0, 327 ] ] } ]
[ { "id": "split_0_train_5342_entity", "type": "progene_text", "text": [ "NK-TR" ], "offsets": [ [ 57, 62 ] ], "normalized": [] }, { "id": "split_0_train_5343_entity", "type": "progene_text", "text": [ "NK-TR" ], "offsets": [ [ 166, 171 ] ], "normalized": [] }, { "id": "split_0_train_5344_entity", "type": "progene_text", "text": [ "MHC" ], "offsets": [ [ 209, 212 ] ], "normalized": [] }, { "id": "split_0_train_5345_entity", "type": "progene_text", "text": [ "NK-TR" ], "offsets": [ [ 250, 255 ] ], "normalized": [] }, { "id": "split_0_train_5346_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 276, 279 ] ], "normalized": [] }, { "id": "split_0_train_5347_entity", "type": "progene_text", "text": [ "Ly-49" ], "offsets": [ [ 307, 312 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3305
split_0_train_3305
[ { "id": "split_0_train_3305_passage", "type": "progene_text", "text": [ "Using short term culture of fresh human or mouse NK cells , antisense NK - TR - treated NK cells demonstrated strong selective reduction of NK cytotoxicity ." ], "offsets": [ [ 0, 157 ] ] } ]
[ { "id": "split_0_train_5348_entity", "type": "progene_text", "text": [ "NK - TR" ], "offsets": [ [ 70, 77 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3306
split_0_train_3306
[ { "id": "split_0_train_3306_passage", "type": "progene_text", "text": [ "NK-TR was necessary for lytic activity even when KIR function was blocked by Ab in experiments involving NK3.3 lysis of HLA.cw3 - expressing targets or killing of Dd targets by Ly-49A + or Ly-49G2 + mouse NK cells ." ], "offsets": [ [ 0, 215 ] ] } ]
[ { "id": "split_0_train_5349_entity", "type": "progene_text", "text": [ "NK-TR" ], "offsets": [ [ 0, 5 ] ], "normalized": [] }, { "id": "split_0_train_5350_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 49, 52 ] ], "normalized": [] }, { "id": "split_0_train_5351_entity", "type": "progene_text", "text": [ "HLA.cw3" ], "offsets": [ [ 120, 127 ] ], "normalized": [] }, { "id": "split_0_train_5352_entity", "type": "progene_text", "text": [ "Ly-49A" ], "offsets": [ [ 177, 183 ] ], "normalized": [] }, { "id": "split_0_train_5353_entity", "type": "progene_text", "text": [ "Ly-49G2" ], "offsets": [ [ 189, 196 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3307
split_0_train_3307
[ { "id": "split_0_train_3307_passage", "type": "progene_text", "text": [ "These studies extend our previous studies in rat NK cell lines to demonstrate that primary mouse and human NK cells require NK-TR for non - MHC - restricted lysis of tumor and virus - infected targets ." ], "offsets": [ [ 0, 202 ] ] } ]
[ { "id": "split_0_train_5354_entity", "type": "progene_text", "text": [ "NK-TR" ], "offsets": [ [ 124, 129 ] ], "normalized": [] }, { "id": "split_0_train_5355_entity", "type": "progene_text", "text": [ "MHC" ], "offsets": [ [ 140, 143 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3308
split_0_train_3308
[ { "id": "split_0_train_3308_passage", "type": "progene_text", "text": [ "In addition , the reversal of KIR or Ly-49 inhibition of NK cell lysis requires NK-TR expression for cellular killing in both human and mouse ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_5356_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 30, 33 ] ], "normalized": [] }, { "id": "split_0_train_5357_entity", "type": "progene_text", "text": [ "Ly-49" ], "offsets": [ [ 37, 42 ] ], "normalized": [] }, { "id": "split_0_train_5358_entity", "type": "progene_text", "text": [ "NK-TR" ], "offsets": [ [ 80, 85 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3309
split_0_train_3309
[ { "id": "split_0_train_3309_passage", "type": "progene_text", "text": [ "Identification and characterization of sporulation - dependent promoters upstream of the enterotoxin gene ( cpe ) of Clostridium perfringens ." ], "offsets": [ [ 0, 142 ] ] } ]
[ { "id": "split_0_train_5359_entity", "type": "progene_text", "text": [ "enterotoxin" ], "offsets": [ [ 89, 100 ] ], "normalized": [] }, { "id": "split_0_train_5360_entity", "type": "progene_text", "text": [ "cpe" ], "offsets": [ [ 108, 111 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3310
split_0_train_3310
[ { "id": "split_0_train_3310_passage", "type": "progene_text", "text": [ "Three promoter sites ( P1 , P2 , and P3 ) responsible for the sporulation - associated synthesis of Clostridium perfringens enterotoxin , a common cause of food poisoning in humans and animals , were identified ." ], "offsets": [ [ 0, 212 ] ] } ]
[ { "id": "split_0_train_5361_entity", "type": "progene_text", "text": [ "enterotoxin" ], "offsets": [ [ 124, 135 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3311
split_0_train_3311
[ { "id": "split_0_train_3311_passage", "type": "progene_text", "text": [ "Nested and internal deletions of the cpe promoter region were made to narrow down the location of promoter elements ." ], "offsets": [ [ 0, 117 ] ] } ]
[]
[]
[]
[]
split_0_train_3312
split_0_train_3312
[ { "id": "split_0_train_3312_passage", "type": "progene_text", "text": [ "To measure the effects of the deletions on the expression of cpe , translational fusions containing the promoter deletions were made with the gusA gene of Escherichia coli , which codes for beta-glucuronidase ; E. coli-C. perfringens shuttle vectors carrying the fusions were introduced into C. perfringens by electroporation ." ], "offsets": [ [ 0, 327 ] ] } ]
[ { "id": "split_0_train_5362_entity", "type": "progene_text", "text": [ "cpe" ], "offsets": [ [ 61, 64 ] ], "normalized": [] }, { "id": "split_0_train_5363_entity", "type": "progene_text", "text": [ "gusA" ], "offsets": [ [ 142, 146 ] ], "normalized": [] }, { "id": "split_0_train_5364_entity", "type": "progene_text", "text": [ "beta-glucuronidase" ], "offsets": [ [ 190, 208 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3313
split_0_train_3313
[ { "id": "split_0_train_3313_passage", "type": "progene_text", "text": [ "In addition , in vitro transcription assays were performed with the cpe promoter region as the DNA template for extracts made from sporulating cells ." ], "offsets": [ [ 0, 150 ] ] } ]
[]
[]
[]
[]
split_0_train_3314
split_0_train_3314
[ { "id": "split_0_train_3314_passage", "type": "progene_text", "text": [ "DNA sequences upstream of P1 were similar to consensus SigK - dependent promoters , while P2 and P3 were similar to consensus SigE - dependent promoters ." ], "offsets": [ [ 0, 154 ] ] } ]
[ { "id": "split_0_train_5365_entity", "type": "progene_text", "text": [ "SigK" ], "offsets": [ [ 55, 59 ] ], "normalized": [] }, { "id": "split_0_train_5366_entity", "type": "progene_text", "text": [ "SigE" ], "offsets": [ [ 126, 130 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3315
split_0_train_3315
[ { "id": "split_0_train_3315_passage", "type": "progene_text", "text": [ "SigE and SigK are sporulation - associated sigma factors known to be active in the mother cell compartment of sporulating cells of Bacillus subtilis , the same compartment in which enterotoxin is synthesized in C. perfringens ." ], "offsets": [ [ 0, 227 ] ] } ]
[ { "id": "split_0_train_5367_entity", "type": "progene_text", "text": [ "SigE" ], "offsets": [ [ 0, 4 ] ], "normalized": [] }, { "id": "split_0_train_5368_entity", "type": "progene_text", "text": [ "SigK" ], "offsets": [ [ 9, 13 ] ], "normalized": [] }, { "id": "split_0_train_5369_entity", "type": "progene_text", "text": [ "sigma factors" ], "offsets": [ [ 43, 56 ] ], "normalized": [] }, { "id": "split_0_train_5370_entity", "type": "progene_text", "text": [ "enterotoxin" ], "offsets": [ [ 181, 192 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3316
split_0_train_3316
[ { "id": "split_0_train_3316_passage", "type": "progene_text", "text": [ "Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition ." ], "offsets": [ [ 0, 124 ] ] } ]
[ { "id": "split_0_train_5371_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 96, 101 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3317
split_0_train_3317
[ { "id": "split_0_train_3317_passage", "type": "progene_text", "text": [ "Cytotoxicity of human NK cells is under negative control of killer cell Ig - like receptors ( KIR ) specific for HLA class I ." ], "offsets": [ [ 0, 126 ] ] } ]
[ { "id": "split_0_train_5372_entity", "type": "progene_text", "text": [ "killer cell Ig - like receptors" ], "offsets": [ [ 60, 91 ] ], "normalized": [] }, { "id": "split_0_train_5373_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 94, 97 ] ], "normalized": [] }, { "id": "split_0_train_5374_entity", "type": "progene_text", "text": [ "HLA class I" ], "offsets": [ [ 113, 124 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3318
split_0_train_3318
[ { "id": "split_0_train_3318_passage", "type": "progene_text", "text": [ "To determine the specificity of five KIR containing two Ig domains ( KIR2D ) , direct binding of soluble recombinant KIR2D to a panel of HLA class I transfectants was assayed ." ], "offsets": [ [ 0, 176 ] ] } ]
[ { "id": "split_0_train_5375_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 37, 40 ] ], "normalized": [] }, { "id": "split_0_train_5376_entity", "type": "progene_text", "text": [ "Ig" ], "offsets": [ [ 56, 58 ] ], "normalized": [] }, { "id": "split_0_train_5377_entity", "type": "progene_text", "text": [ "KIR2D" ], "offsets": [ [ 69, 74 ] ], "normalized": [] }, { "id": "split_0_train_5378_entity", "type": "progene_text", "text": [ "KIR2D" ], "offsets": [ [ 117, 122 ] ], "normalized": [] }, { "id": "split_0_train_5379_entity", "type": "progene_text", "text": [ "HLA class I" ], "offsets": [ [ 137, 148 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3319
split_0_train_3319
[ { "id": "split_0_train_3319_passage", "type": "progene_text", "text": [ "One soluble KIR2D , derived from an inhibitory receptor with a long cytoplasmic tail ( KIR2DL1 ) , bound to HLA-C allotypes containing asparagine 77 and lysine 80 in the heavy chain , as expected , since these allotypes inhibit lysis by NK cells expressing KIR2DL1 ." ], "offsets": [ [ 0, 266 ] ] } ]
[ { "id": "split_0_train_5380_entity", "type": "progene_text", "text": [ "KIR2D" ], "offsets": [ [ 12, 17 ] ], "normalized": [] }, { "id": "split_0_train_5381_entity", "type": "progene_text", "text": [ "KIR2DL1" ], "offsets": [ [ 87, 94 ] ], "normalized": [] }, { "id": "split_0_train_5382_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 108, 113 ] ], "normalized": [] }, { "id": "split_0_train_5383_entity", "type": "progene_text", "text": [ "KIR2DL1" ], "offsets": [ [ 257, 264 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3320
split_0_train_3320
[ { "id": "split_0_train_3320_passage", "type": "progene_text", "text": [ "Surprisingly , another KIR2D ( KIR2DL2 ) , which inhibits NK lysis of cells expressing HLA-C molecules with serine 77 and asparagine 80 , bound to HLA-C allotypes carrying either amino acid motif ." ], "offsets": [ [ 0, 197 ] ] } ]
[ { "id": "split_0_train_5384_entity", "type": "progene_text", "text": [ "KIR2D" ], "offsets": [ [ 23, 28 ] ], "normalized": [] }, { "id": "split_0_train_5385_entity", "type": "progene_text", "text": [ "KIR2DL2" ], "offsets": [ [ 31, 38 ] ], "normalized": [] }, { "id": "split_0_train_5386_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 87, 92 ] ], "normalized": [] }, { "id": "split_0_train_5387_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 147, 152 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3321
split_0_train_3321
[ { "id": "split_0_train_3321_passage", "type": "progene_text", "text": [ "Expression of the KIR2DL receptors in NK cells using recombinant vaccinia viruses confirmed these patterns of recognition , and identified KIR2DL3 as another KIR reacting with both groups of HLA-C allotypes ." ], "offsets": [ [ 0, 208 ] ] } ]
[ { "id": "split_0_train_5388_entity", "type": "progene_text", "text": [ "KIR2DL" ], "offsets": [ [ 18, 24 ] ], "normalized": [] }, { "id": "split_0_train_5389_entity", "type": "progene_text", "text": [ "KIR2DL3" ], "offsets": [ [ 139, 146 ] ], "normalized": [] }, { "id": "split_0_train_5390_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 158, 161 ] ], "normalized": [] }, { "id": "split_0_train_5391_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 191, 196 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3322
split_0_train_3322
[ { "id": "split_0_train_3322_passage", "type": "progene_text", "text": [ "Mutagenesis of amino acid 44 in KIR2DL1 and KIR2DL2 suggested this residue controls the affinity of KIR for the 77 / 80 motif of HLA-C molecules ." ], "offsets": [ [ 0, 146 ] ] } ]
[ { "id": "split_0_train_5392_entity", "type": "progene_text", "text": [ "KIR2DL1" ], "offsets": [ [ 32, 39 ] ], "normalized": [] }, { "id": "split_0_train_5393_entity", "type": "progene_text", "text": [ "KIR2DL2" ], "offsets": [ [ 44, 51 ] ], "normalized": [] }, { "id": "split_0_train_5394_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 100, 103 ] ], "normalized": [] }, { "id": "split_0_train_5395_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 129, 134 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3323
split_0_train_3323
[ { "id": "split_0_train_3323_passage", "type": "progene_text", "text": [ "Two other soluble KIR2D , derived from noninhibitory receptors with short cytoplasmic tails ( KIR2DS ) , did not bind to any of the HLA class I allotypes tested ." ], "offsets": [ [ 0, 162 ] ] } ]
[ { "id": "split_0_train_5396_entity", "type": "progene_text", "text": [ "KIR2D" ], "offsets": [ [ 18, 23 ] ], "normalized": [] }, { "id": "split_0_train_5397_entity", "type": "progene_text", "text": [ "KIR2DS" ], "offsets": [ [ 94, 100 ] ], "normalized": [] }, { "id": "split_0_train_5398_entity", "type": "progene_text", "text": [ "HLA class I" ], "offsets": [ [ 132, 143 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3324
split_0_train_3324
[ { "id": "split_0_train_3324_passage", "type": "progene_text", "text": [ "One of these receptors ( KIR2DS2 ) is closely related in sequence to KIR2DL2 ." ], "offsets": [ [ 0, 78 ] ] } ]
[ { "id": "split_0_train_5399_entity", "type": "progene_text", "text": [ "KIR2DS2" ], "offsets": [ [ 25, 32 ] ], "normalized": [] }, { "id": "split_0_train_5400_entity", "type": "progene_text", "text": [ "KIR2DL2" ], "offsets": [ [ 69, 76 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3325
split_0_train_3325
[ { "id": "split_0_train_3325_passage", "type": "progene_text", "text": [ "Substitution of tyrosine 45 with the phenylalanine conserved in other KIR was sufficient to permit specific binding of KIR2DS2 to HLA-C ." ], "offsets": [ [ 0, 137 ] ] } ]
[ { "id": "split_0_train_5401_entity", "type": "progene_text", "text": [ "KIR" ], "offsets": [ [ 70, 73 ] ], "normalized": [] }, { "id": "split_0_train_5402_entity", "type": "progene_text", "text": [ "KIR2DS2" ], "offsets": [ [ 119, 126 ] ], "normalized": [] }, { "id": "split_0_train_5403_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 130, 135 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3326
split_0_train_3326
[ { "id": "split_0_train_3326_passage", "type": "progene_text", "text": [ "These results show that KIR2DL receptors are specific for HLA-C , but that recognition of HLA-C allotypes appears more permissive than indicated by previous functional experiments ." ], "offsets": [ [ 0, 181 ] ] } ]
[ { "id": "split_0_train_5404_entity", "type": "progene_text", "text": [ "KIR2DL" ], "offsets": [ [ 24, 30 ] ], "normalized": [] }, { "id": "split_0_train_5405_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 58, 63 ] ], "normalized": [] }, { "id": "split_0_train_5406_entity", "type": "progene_text", "text": [ "HLA-C" ], "offsets": [ [ 90, 95 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3327
split_0_train_3327
[ { "id": "split_0_train_3327_passage", "type": "progene_text", "text": [ "Molecular cloning of the oncofetal isoform of the human pancreatic bile salt - dependent lipase ." ], "offsets": [ [ 0, 97 ] ] } ]
[ { "id": "split_0_train_5407_entity", "type": "progene_text", "text": [ "bile salt - dependent lipase" ], "offsets": [ [ 67, 95 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3328
split_0_train_3328
[ { "id": "split_0_train_3328_passage", "type": "progene_text", "text": [ "Specific transcripts for bile salt - dependent lipase ( BSDL ) , a 100 - kDa glycoprotein secreted by the human pancreas , were immunodetected in BxPC-3 and SOJ-6 pancreatic tumoral cell lines ." ], "offsets": [ [ 0, 194 ] ] } ]
[ { "id": "split_0_train_5408_entity", "type": "progene_text", "text": [ "bile salt - dependent lipase" ], "offsets": [ [ 25, 53 ] ], "normalized": [] }, { "id": "split_0_train_5409_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 56, 60 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3329
split_0_train_3329
[ { "id": "split_0_train_3329_passage", "type": "progene_text", "text": [ "Sequencing of fragments , obtained by mRNA reverse transcription and amplification , confirmed the presence of BSDL transcripts in these cancer cells ." ], "offsets": [ [ 0, 151 ] ] } ]
[ { "id": "split_0_train_5410_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 111, 115 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3330
split_0_train_3330
[ { "id": "split_0_train_3330_passage", "type": "progene_text", "text": [ "The protein was detected in lysates of pancreatic tumoral cells , where it was mainly associated with membranes ." ], "offsets": [ [ 0, 113 ] ] } ]
[]
[]
[]
[]
split_0_train_3331
split_0_train_3331
[ { "id": "split_0_train_3331_passage", "type": "progene_text", "text": [ "Only a minute amount of the enzyme was detected in the culture media ." ], "offsets": [ [ 0, 70 ] ] } ]
[]
[]
[]
[]
split_0_train_3332
split_0_train_3332
[ { "id": "split_0_train_3332_passage", "type": "progene_text", "text": [ "Immunofluorescence studies demonstrated that in SOJ-6 cells , BSDL colocates with the p58 Golgi protein and suggested that the protein may be sequestrated within the Golgi compartment ." ], "offsets": [ [ 0, 185 ] ] } ]
[ { "id": "split_0_train_5411_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 62, 66 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3333
split_0_train_3333
[ { "id": "split_0_train_3333_passage", "type": "progene_text", "text": [ "These results demonstrated that BSDL is expressed in human pancreatic tumoral cells and cannot be secreted ( or for the least very poorly ) ." ], "offsets": [ [ 0, 141 ] ] } ]
[ { "id": "split_0_train_5412_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 32, 36 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3334
split_0_train_3334
[ { "id": "split_0_train_3334_passage", "type": "progene_text", "text": [ "Subsequently , a cDNA covering the entire sequence of BSDL was obtained by reverse transcription - polymerase chain reaction ." ], "offsets": [ [ 0, 126 ] ] } ]
[ { "id": "split_0_train_5413_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 54, 58 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3335
split_0_train_3335
[ { "id": "split_0_train_3335_passage", "type": "progene_text", "text": [ "The sequence of this cDNA indicated that the N - terminal domain encoded by exons 1 - 10 was identical to that of BSDL expressed by the human normal pancreas ." ], "offsets": [ [ 0, 159 ] ] } ]
[ { "id": "split_0_train_5414_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 114, 118 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3336
split_0_train_3336
[ { "id": "split_0_train_3336_passage", "type": "progene_text", "text": [ "However , the sequence corresponding to exon 11 , which should code for the 16 tandem - repeated identical mucin - like sequences of BSDL , was deleted by 330 base pairs ( bp ) and encoded only 6 of these repeated sequences ." ], "offsets": [ [ 0, 225 ] ] } ]
[ { "id": "split_0_train_5415_entity", "type": "progene_text", "text": [ "mucin" ], "offsets": [ [ 107, 112 ] ], "normalized": [] }, { "id": "split_0_train_5416_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 133, 137 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3337
split_0_train_3337
[ { "id": "split_0_train_3337_passage", "type": "progene_text", "text": [ "We conclude that this truncated variant of BSDL would be its oncofetal form , referred to as feto - acinar pancreatic protein ." ], "offsets": [ [ 0, 127 ] ] } ]
[ { "id": "split_0_train_5417_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 43, 47 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3338
split_0_train_3338
[ { "id": "split_0_train_3338_passage", "type": "progene_text", "text": [ "We then investigated whether the deletion of 330 bp affected the secretion of the protein ." ], "offsets": [ [ 0, 91 ] ] } ]
[]
[]
[]
[]
split_0_train_3339
split_0_train_3339
[ { "id": "split_0_train_3339_passage", "type": "progene_text", "text": [ "For this purpose , the cDNA corresponding to the mature form of the BSDL variant expressed in SOJ-6 cells was cloned into an expression / secretion vector and transfected into CHO-K1 cells ." ], "offsets": [ [ 0, 190 ] ] } ]
[ { "id": "split_0_train_5418_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 68, 72 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3340
split_0_train_3340
[ { "id": "split_0_train_3340_passage", "type": "progene_text", "text": [ "Results indicated that the variant of BSDL isolated from SOJ-6 cells was expressed and secreted by transfected cells ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_5419_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 38, 42 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3341
split_0_train_3341
[ { "id": "split_0_train_3341_passage", "type": "progene_text", "text": [ "However , the level of BSDL secreted by these transfected CHO-K1 cells was significantly higher than that observed for SOJ-6 cells ." ], "offsets": [ [ 0, 132 ] ] } ]
[ { "id": "split_0_train_5420_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 23, 27 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3342
split_0_train_3342
[ { "id": "split_0_train_3342_passage", "type": "progene_text", "text": [ "Consequently , the retention of the oncofetal variant of BSDL observed in human pancreatic tumoral cells might not result from inherent properties of the protein ." ], "offsets": [ [ 0, 163 ] ] } ]
[ { "id": "split_0_train_5421_entity", "type": "progene_text", "text": [ "BSDL" ], "offsets": [ [ 57, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3343
split_0_train_3343
[ { "id": "split_0_train_3343_passage", "type": "progene_text", "text": [ "Cloning and characterization of RLPK , a novel RSK - related protein kinase ." ], "offsets": [ [ 0, 77 ] ] } ]
[ { "id": "split_0_train_5422_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 32, 36 ] ], "normalized": [] }, { "id": "split_0_train_5423_entity", "type": "progene_text", "text": [ "RSK" ], "offsets": [ [ 47, 50 ] ], "normalized": [] }, { "id": "split_0_train_5424_entity", "type": "progene_text", "text": [ "protein kinase" ], "offsets": [ [ 61, 75 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3344
split_0_train_3344
[ { "id": "split_0_train_3344_passage", "type": "progene_text", "text": [ "A novel protein kinase whose activity can be stimulated by mitogen in vivo was cloned and characterized ." ], "offsets": [ [ 0, 105 ] ] } ]
[ { "id": "split_0_train_5425_entity", "type": "progene_text", "text": [ "protein kinase" ], "offsets": [ [ 8, 22 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3345
split_0_train_3345
[ { "id": "split_0_train_3345_passage", "type": "progene_text", "text": [ "The cDNA of this gene encodes an 802-amino acid protein ( termed RLPK ) with the highest homology ( 37 % identity ) to the two protein kinase families , p90 ( RSK ) and p70 ( RSK ) ." ], "offsets": [ [ 0, 182 ] ] } ]
[ { "id": "split_0_train_5426_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 65, 69 ] ], "normalized": [] }, { "id": "split_0_train_5427_entity", "type": "progene_text", "text": [ "protein kinase" ], "offsets": [ [ 127, 141 ] ], "normalized": [] }, { "id": "split_0_train_5428_entity", "type": "progene_text", "text": [ "p90 ( RSK )" ], "offsets": [ [ 153, 164 ] ], "normalized": [] }, { "id": "split_0_train_5429_entity", "type": "progene_text", "text": [ "p70 ( RSK )" ], "offsets": [ [ 169, 180 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3346
split_0_train_3346
[ { "id": "split_0_train_3346_passage", "type": "progene_text", "text": [ "Like p90 ( RSR ) , but not p70 ( RSK ) , RLPK also contains two complete nonidentical protein kinase domains ." ], "offsets": [ [ 0, 110 ] ] } ]
[ { "id": "split_0_train_5430_entity", "type": "progene_text", "text": [ "p90 ( RSR )" ], "offsets": [ [ 5, 16 ] ], "normalized": [] }, { "id": "split_0_train_5431_entity", "type": "progene_text", "text": [ "p70 ( RSK )" ], "offsets": [ [ 27, 38 ] ], "normalized": [] }, { "id": "split_0_train_5432_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 41, 45 ] ], "normalized": [] }, { "id": "split_0_train_5433_entity", "type": "progene_text", "text": [ "protein kinase" ], "offsets": [ [ 86, 100 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3347
split_0_train_3347
[ { "id": "split_0_train_3347_passage", "type": "progene_text", "text": [ "RLPK mRNA is widely expressed in all human tissues examined and is enriched in the brain , heart , and placenta ." ], "offsets": [ [ 0, 113 ] ] } ]
[ { "id": "split_0_train_5434_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 0, 4 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3348
split_0_train_3348
[ { "id": "split_0_train_3348_passage", "type": "progene_text", "text": [ "In HeLa cells , transiently expressed epitope - tagged RLPK can be strongly induced by epidermal growth factor , serum , and phorbol 12-myristate 13-acetate , but only moderately up - regulated by tumor necrosis factor - alpha and other stress - related stimuli ." ], "offsets": [ [ 0, 263 ] ] } ]
[ { "id": "split_0_train_5435_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 55, 59 ] ], "normalized": [] }, { "id": "split_0_train_5436_entity", "type": "progene_text", "text": [ "epidermal growth factor" ], "offsets": [ [ 87, 110 ] ], "normalized": [] }, { "id": "split_0_train_5437_entity", "type": "progene_text", "text": [ "tumor necrosis factor - alpha" ], "offsets": [ [ 197, 226 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3349
split_0_train_3349
[ { "id": "split_0_train_3349_passage", "type": "progene_text", "text": [ "The activity of RLPK stimulated by epidermal growth factor was not inhibited by several known protein kinase C inhibitors nor by rapamycin , a known specific inhibitor for p70 ( RSK ) , but could be inhibited by herbimycin A , a tyrosine kinase inhibitor , and partially inhibited by PD98059 or SB203580 , inhibitors for the mitogen - activated protein kinase pathways ." ], "offsets": [ [ 0, 370 ] ] } ]
[ { "id": "split_0_train_5438_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 16, 20 ] ], "normalized": [] }, { "id": "split_0_train_5439_entity", "type": "progene_text", "text": [ "epidermal growth factor" ], "offsets": [ [ 35, 58 ] ], "normalized": [] }, { "id": "split_0_train_5440_entity", "type": "progene_text", "text": [ "protein kinase C" ], "offsets": [ [ 94, 110 ] ], "normalized": [] }, { "id": "split_0_train_5441_entity", "type": "progene_text", "text": [ "p70 ( RSK )" ], "offsets": [ [ 172, 183 ] ], "normalized": [] }, { "id": "split_0_train_5442_entity", "type": "progene_text", "text": [ "tyrosine kinase" ], "offsets": [ [ 229, 244 ] ], "normalized": [] }, { "id": "split_0_train_5443_entity", "type": "progene_text", "text": [ "mitogen - activated protein kinase" ], "offsets": [ [ 325, 359 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3350
split_0_train_3350
[ { "id": "split_0_train_3350_passage", "type": "progene_text", "text": [ "Recombinant RLPK possesses high phosphorylation activity toward histone 2B and the S6 peptide , RRRLSSLRA ." ], "offsets": [ [ 0, 107 ] ] } ]
[ { "id": "split_0_train_5444_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 12, 16 ] ], "normalized": [] }, { "id": "split_0_train_5445_entity", "type": "progene_text", "text": [ "histone 2B" ], "offsets": [ [ 64, 74 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3351
split_0_train_3351
[ { "id": "split_0_train_3351_passage", "type": "progene_text", "text": [ "Although purified recombinant RLPK can be phosphorylated by ERK2 and p38alpha in vitro , its activity is not affected by this phosphorylation ." ], "offsets": [ [ 0, 143 ] ] } ]
[ { "id": "split_0_train_5446_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 30, 34 ] ], "normalized": [] }, { "id": "split_0_train_5447_entity", "type": "progene_text", "text": [ "ERK2" ], "offsets": [ [ 60, 64 ] ], "normalized": [] }, { "id": "split_0_train_5448_entity", "type": "progene_text", "text": [ "p38alpha" ], "offsets": [ [ 69, 77 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3352
split_0_train_3352
[ { "id": "split_0_train_3352_passage", "type": "progene_text", "text": [ "Moreover , the treatment of RLPK with acid phosphatase did not reduce its in vitro kinase activity ." ], "offsets": [ [ 0, 100 ] ] } ]
[ { "id": "split_0_train_5449_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 28, 32 ] ], "normalized": [] }, { "id": "split_0_train_5450_entity", "type": "progene_text", "text": [ "acid phosphatase" ], "offsets": [ [ 38, 54 ] ], "normalized": [] }, { "id": "split_0_train_5451_entity", "type": "progene_text", "text": [ "kinase" ], "offsets": [ [ 83, 89 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3353
split_0_train_3353
[ { "id": "split_0_train_3353_passage", "type": "progene_text", "text": [ "These data suggest that RLPK is structurally similar to previously isolated RSKs , but its regulatory mechanism may be distinct from either p70 ( RSK ) or p90(RSK)s ." ], "offsets": [ [ 0, 166 ] ] } ]
[ { "id": "split_0_train_5452_entity", "type": "progene_text", "text": [ "RLPK" ], "offsets": [ [ 24, 28 ] ], "normalized": [] }, { "id": "split_0_train_5453_entity", "type": "progene_text", "text": [ "RSKs" ], "offsets": [ [ 76, 80 ] ], "normalized": [] }, { "id": "split_0_train_5454_entity", "type": "progene_text", "text": [ "p70 ( RSK )" ], "offsets": [ [ 140, 151 ] ], "normalized": [] }, { "id": "split_0_train_5455_entity", "type": "progene_text", "text": [ "p90(RSK)s" ], "offsets": [ [ 155, 164 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3354
split_0_train_3354
[ { "id": "split_0_train_3354_passage", "type": "progene_text", "text": [ "Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol , atenolol or diltiazem in conscious dogs ." ], "offsets": [ [ 0, 137 ] ] } ]
[]
[]
[]
[]
split_0_train_3355
split_0_train_3355
[ { "id": "split_0_train_3355_passage", "type": "progene_text", "text": [ "In support of clinical antianginal studies , the vasodilator nicorandil ( NIC ) was combined with the beta-adrenergic receptor antagonists propranolol ( PRO ) and atenolol ( ATN ) and with the calcium channel blocker diltiazem ( DTZ ) to determine their cardiovascular and pharmacokinetic interactions ." ], "offsets": [ [ 0, 303 ] ] } ]
[ { "id": "split_0_train_5456_entity", "type": "progene_text", "text": [ "beta-adrenergic receptor" ], "offsets": [ [ 102, 126 ] ], "normalized": [] }, { "id": "split_0_train_5457_entity", "type": "progene_text", "text": [ "calcium channel" ], "offsets": [ [ 193, 208 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3356
split_0_train_3356
[ { "id": "split_0_train_3356_passage", "type": "progene_text", "text": [ "Beagle dogs were chronically cannulated to record mean arterial pressure , heart rate , and the lead II electrocardiogram under conscious conditions ." ], "offsets": [ [ 0, 150 ] ] } ]
[]
[]
[]
[]
split_0_train_3357
split_0_train_3357
[ { "id": "split_0_train_3357_passage", "type": "progene_text", "text": [ "Oral NIC ( 1 , 3 , and 10 mg / kg ) was coadministered with i.v. PRO ( 5.0 mg / kg ) or ATN ( 7.5 mg / kg ) , both of which lessened NIC's reflex tachycardia ." ], "offsets": [ [ 0, 159 ] ] } ]
[]
[]
[]
[]
split_0_train_3358
split_0_train_3358
[ { "id": "split_0_train_3358_passage", "type": "progene_text", "text": [ "ECG rhythm remained normal , but both beta-blockers restricted high dose NIC 's QTc prolongation and ST segment depression ." ], "offsets": [ [ 0, 124 ] ] } ]
[]
[]
[]
[]
split_0_train_3359
split_0_train_3359
[ { "id": "split_0_train_3359_passage", "type": "progene_text", "text": [ "Intravenous DTZ ( 5 - 23 micrograms / kg / min ) did not affect i.v. NIC's hypotensive profile ( 10 - 80 micrograms / kg / min ) but attenuated its tachycardia , whereas NIC-reversed DTZ's PR interval shortening and frequency of ectopic beats ." ], "offsets": [ [ 0, 244 ] ] } ]
[]
[]
[]
[]
split_0_train_3360
split_0_train_3360
[ { "id": "split_0_train_3360_passage", "type": "progene_text", "text": [ "Similar cardiovascular interactions were seen with chronic oral DTZ ( 10 mg / kg / day ) + NIC ( 3.0 or 7.5 mg / kg ) ." ], "offsets": [ [ 0, 119 ] ] } ]
[]
[]
[]
[]
split_0_train_3361
split_0_train_3361
[ { "id": "split_0_train_3361_passage", "type": "progene_text", "text": [ "Plasma analysis confirmed that none of the adjuncts affected NIC 's disposition nor its concentration - dependent hypotensive response profile ." ], "offsets": [ [ 0, 144 ] ] } ]
[]
[]
[]
[]
split_0_train_3362
split_0_train_3362
[ { "id": "split_0_train_3362_passage", "type": "progene_text", "text": [ "These studies establish the cardiovascular effects of NIC when combined with PRO , ATN or DTZ in dogs , and outline paradigms useful for evaluating such antianginal drug combinations ." ], "offsets": [ [ 0, 184 ] ] } ]
[]
[]
[]
[]
split_0_train_3363
split_0_train_3363
[ { "id": "split_0_train_3363_passage", "type": "progene_text", "text": [ "Analysis of two cosmid clones from chromosome 4 of Drosophila melanogaster reveals two new genes amid an unusual arrangement of repeated sequences ." ], "offsets": [ [ 0, 148 ] ] } ]
[]
[]
[]
[]
split_0_train_3364
split_0_train_3364
[ { "id": "split_0_train_3364_passage", "type": "progene_text", "text": [ "Chromosome 4 from Drosophila melanogaster has several unusual features that distinguish it from the other chromosomes ." ], "offsets": [ [ 0, 119 ] ] } ]
[]
[]
[]
[]
split_0_train_3365
split_0_train_3365
[ { "id": "split_0_train_3365_passage", "type": "progene_text", "text": [ "These include a diffuse appearance in salivary gland polytene chromosomes , an absence of recombination , and the variegated expression of P-element transgenes ." ], "offsets": [ [ 0, 161 ] ] } ]
[]
[]
[]
[]
split_0_train_3366
split_0_train_3366
[ { "id": "split_0_train_3366_passage", "type": "progene_text", "text": [ "As part of a larger project to understand these properties , we are assembling a physical map of this chromosome ." ], "offsets": [ [ 0, 114 ] ] } ]
[]
[]
[]
[]
split_0_train_3367
split_0_train_3367
[ { "id": "split_0_train_3367_passage", "type": "progene_text", "text": [ "Here we report the sequence of two cosmids representing approximately 5 % of the polytenized region ." ], "offsets": [ [ 0, 101 ] ] } ]
[]
[]
[]
[]
split_0_train_3368
split_0_train_3368
[ { "id": "split_0_train_3368_passage", "type": "progene_text", "text": [ "Both cosmid clones contain numerous repeated DNA sequences , as identified by cross hybridization with labeled genomic DNA , BLAST searches , and dot matrix analysis , which are positioned between and within the transcribed sequences ." ], "offsets": [ [ 0, 235 ] ] } ]
[]
[]
[]
[]
split_0_train_3369
split_0_train_3369
[ { "id": "split_0_train_3369_passage", "type": "progene_text", "text": [ "The repetitive sequences include three copies of the mobile element Hoppel , one copy of the mobile element HB , and 18 DINE repeats ." ], "offsets": [ [ 0, 134 ] ] } ]
[]
[]
[]
[]
split_0_train_3370
split_0_train_3370
[ { "id": "split_0_train_3370_passage", "type": "progene_text", "text": [ "DINE is a novel , short repeated sequence dispersed throughout both cosmid sequences ." ], "offsets": [ [ 0, 86 ] ] } ]
[]
[]
[]
[]
split_0_train_3371
split_0_train_3371
[ { "id": "split_0_train_3371_passage", "type": "progene_text", "text": [ "One cosmid includes the previously described cubitus interruptus ( ci ) gene and two new genes : that a gene with a predicted amino acid sequence similar to ribosomal protein S3a which is consistent with the Minute(4) 101 locus thought to be in the region , and a novel member of the protein family that includes plexin and met - hepatocyte growth factor receptor ." ], "offsets": [ [ 0, 365 ] ] } ]
[ { "id": "split_0_train_5458_entity", "type": "progene_text", "text": [ "cubitus interruptus" ], "offsets": [ [ 45, 64 ] ], "normalized": [] }, { "id": "split_0_train_5459_entity", "type": "progene_text", "text": [ "ci" ], "offsets": [ [ 67, 69 ] ], "normalized": [] }, { "id": "split_0_train_5460_entity", "type": "progene_text", "text": [ "ribosomal protein S3a" ], "offsets": [ [ 157, 178 ] ], "normalized": [] }, { "id": "split_0_train_5461_entity", "type": "progene_text", "text": [ "plexin" ], "offsets": [ [ 313, 319 ] ], "normalized": [] }, { "id": "split_0_train_5462_entity", "type": "progene_text", "text": [ "met" ], "offsets": [ [ 324, 327 ] ], "normalized": [] }, { "id": "split_0_train_5463_entity", "type": "progene_text", "text": [ "hepatocyte growth factor receptor" ], "offsets": [ [ 330, 363 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3372
split_0_train_3372
[ { "id": "split_0_train_3372_passage", "type": "progene_text", "text": [ "The other cosmid contains only the two short 5'-most exons from the zinc-finger-homolog-2 ( zfh-2 ) gene ." ], "offsets": [ [ 0, 106 ] ] } ]
[ { "id": "split_0_train_5464_entity", "type": "progene_text", "text": [ "zinc-finger-homolog-2" ], "offsets": [ [ 68, 89 ] ], "normalized": [] }, { "id": "split_0_train_5465_entity", "type": "progene_text", "text": [ "zfh-2" ], "offsets": [ [ 92, 97 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3373
split_0_train_3373
[ { "id": "split_0_train_3373_passage", "type": "progene_text", "text": [ "This is the first extensive sequence analysis of noncoding DNA from chromosome 4 ." ], "offsets": [ [ 0, 82 ] ] } ]
[]
[]
[]
[]
split_0_train_3374
split_0_train_3374
[ { "id": "split_0_train_3374_passage", "type": "progene_text", "text": [ "The distribution of the various repeats suggests its organization is similar to the beta-heterochromatic regions near the base of the major chromosome arms ." ], "offsets": [ [ 0, 157 ] ] } ]
[]
[]
[]
[]
split_0_train_3375
split_0_train_3375
[ { "id": "split_0_train_3375_passage", "type": "progene_text", "text": [ "Such a pattern may account for the diffuse banding of the polytene chromosome 4 and the variegation of many P-element transgenes on the chromosome ." ], "offsets": [ [ 0, 148 ] ] } ]
[]
[]
[]
[]
split_0_train_3376
split_0_train_3376
[ { "id": "split_0_train_3376_passage", "type": "progene_text", "text": [ "Fibroblast growth factor-8 expression is regulated by intronic engrailed and Pbx1 - binding sites ." ], "offsets": [ [ 0, 99 ] ] } ]
[ { "id": "split_0_train_5466_entity", "type": "progene_text", "text": [ "Fibroblast growth factor-8" ], "offsets": [ [ 0, 26 ] ], "normalized": [] }, { "id": "split_0_train_5467_entity", "type": "progene_text", "text": [ "Pbx1" ], "offsets": [ [ 77, 81 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3377
split_0_train_3377
[ { "id": "split_0_train_3377_passage", "type": "progene_text", "text": [ "Fibroblast growth factor-8 ( FGF8 ) plays a critical role in vertebrate development and is expressed normally in temporally and spatially restricted regions of the vertebrate embryo ." ], "offsets": [ [ 0, 183 ] ] } ]
[ { "id": "split_0_train_5468_entity", "type": "progene_text", "text": [ "Fibroblast growth factor-8" ], "offsets": [ [ 0, 26 ] ], "normalized": [] }, { "id": "split_0_train_5469_entity", "type": "progene_text", "text": [ "FGF8" ], "offsets": [ [ 29, 33 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3378
split_0_train_3378
[ { "id": "split_0_train_3378_passage", "type": "progene_text", "text": [ "We now report on the identification of regions of Fgf8 important for its transcriptional regulation in murine ES cell - derived embryoid bodies ." ], "offsets": [ [ 0, 145 ] ] } ]
[ { "id": "split_0_train_5470_entity", "type": "progene_text", "text": [ "Fgf8" ], "offsets": [ [ 50, 54 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3379
split_0_train_3379
[ { "id": "split_0_train_3379_passage", "type": "progene_text", "text": [ "Stable transfection of ES cells , using a human growth hormone reporter gene , was employed to identify regions of the Fgf8 gene with promoter / enhancer activity ." ], "offsets": [ [ 0, 164 ] ] } ]
[ { "id": "split_0_train_5471_entity", "type": "progene_text", "text": [ "growth hormone" ], "offsets": [ [ 48, 62 ] ], "normalized": [] }, { "id": "split_0_train_5472_entity", "type": "progene_text", "text": [ "Fgf8" ], "offsets": [ [ 119, 123 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3380
split_0_train_3380
[ { "id": "split_0_train_3380_passage", "type": "progene_text", "text": [ "A 2-kilobase 5' region of Fgf8 was shown to contain promoter activity ." ], "offsets": [ [ 0, 71 ] ] } ]
[ { "id": "split_0_train_5473_entity", "type": "progene_text", "text": [ "Fgf8" ], "offsets": [ [ 26, 30 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3381
split_0_train_3381
[ { "id": "split_0_train_3381_passage", "type": "progene_text", "text": [ "A 0.8 - kilobase fragment derived from the large intron of Fgf8 was found to enhance human growth hormone expressed from the Fgf8 promoter 3 - 4 - fold in an orientation dependent manner ." ], "offsets": [ [ 0, 188 ] ] } ]
[ { "id": "split_0_train_5474_entity", "type": "progene_text", "text": [ "Fgf8" ], "offsets": [ [ 59, 63 ] ], "normalized": [] }, { "id": "split_0_train_5475_entity", "type": "progene_text", "text": [ "growth hormone" ], "offsets": [ [ 91, 105 ] ], "normalized": [] }, { "id": "split_0_train_5476_entity", "type": "progene_text", "text": [ "Fgf8" ], "offsets": [ [ 125, 129 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3382
split_0_train_3382
[ { "id": "split_0_train_3382_passage", "type": "progene_text", "text": [ "The intronic fragment contains DNA - binding sites for the AP2 , Pbx1 , and Engrailed transcription factors ." ], "offsets": [ [ 0, 109 ] ] } ]
[ { "id": "split_0_train_5477_entity", "type": "progene_text", "text": [ "AP2" ], "offsets": [ [ 59, 62 ] ], "normalized": [] }, { "id": "split_0_train_5478_entity", "type": "progene_text", "text": [ "Pbx1" ], "offsets": [ [ 65, 69 ] ], "normalized": [] }, { "id": "split_0_train_5479_entity", "type": "progene_text", "text": [ "Engrailed" ], "offsets": [ [ 76, 85 ] ], "normalized": [] }, { "id": "split_0_train_5480_entity", "type": "progene_text", "text": [ "transcription factors" ], "offsets": [ [ 86, 107 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3383
split_0_train_3383
[ { "id": "split_0_train_3383_passage", "type": "progene_text", "text": [ "Gel shift and Western blot experiments documented the presence of these transcription factors in nuclear extracts from ES cell embryoid bodies ." ], "offsets": [ [ 0, 144 ] ] } ]
[ { "id": "split_0_train_5481_entity", "type": "progene_text", "text": [ "transcription factors" ], "offsets": [ [ 72, 93 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3384
split_0_train_3384
[ { "id": "split_0_train_3384_passage", "type": "progene_text", "text": [ "In vitro mutagenesis of the Engrailed or Pbx1 site demonstrated that these sites modulate the activity of the intronic fragment ." ], "offsets": [ [ 0, 129 ] ] } ]
[ { "id": "split_0_train_5482_entity", "type": "progene_text", "text": [ "Engrailed" ], "offsets": [ [ 28, 37 ] ], "normalized": [] }, { "id": "split_0_train_5483_entity", "type": "progene_text", "text": [ "Pbx1" ], "offsets": [ [ 41, 45 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3385
split_0_train_3385
[ { "id": "split_0_train_3385_passage", "type": "progene_text", "text": [ "In addition , in vitro mutagenesis of both Engrailed and Pbx1 sites indicated that other unidentified sites are responsible for the transcriptional enhancement observed with the intronic fragment ." ], "offsets": [ [ 0, 197 ] ] } ]
[ { "id": "split_0_train_5484_entity", "type": "progene_text", "text": [ "Engrailed" ], "offsets": [ [ 43, 52 ] ], "normalized": [] }, { "id": "split_0_train_5485_entity", "type": "progene_text", "text": [ "Pbx1" ], "offsets": [ [ 57, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3386
split_0_train_3386
[ { "id": "split_0_train_3386_passage", "type": "progene_text", "text": [ "Discovery of three novel orphan G-protein - coupled receptors ." ], "offsets": [ [ 0, 63 ] ] } ]
[ { "id": "split_0_train_5486_entity", "type": "progene_text", "text": [ "G-protein - coupled receptors" ], "offsets": [ [ 32, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3387
split_0_train_3387
[ { "id": "split_0_train_3387_passage", "type": "progene_text", "text": [ "We have discovered three novel human genes , GPR34 , GPR44 , and GPR45 , encoding family A G - protein - coupled receptors ( GPCRs ) ." ], "offsets": [ [ 0, 134 ] ] } ]
[ { "id": "split_0_train_5487_entity", "type": "progene_text", "text": [ "GPR34" ], "offsets": [ [ 45, 50 ] ], "normalized": [] }, { "id": "split_0_train_5488_entity", "type": "progene_text", "text": [ "GPR44" ], "offsets": [ [ 53, 58 ] ], "normalized": [] }, { "id": "split_0_train_5489_entity", "type": "progene_text", "text": [ "GPR45" ], "offsets": [ [ 65, 70 ] ], "normalized": [] }, { "id": "split_0_train_5490_entity", "type": "progene_text", "text": [ "G - protein - coupled receptors" ], "offsets": [ [ 91, 122 ] ], "normalized": [] }, { "id": "split_0_train_5491_entity", "type": "progene_text", "text": [ "GPCRs" ], "offsets": [ [ 125, 130 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3388
split_0_train_3388
[ { "id": "split_0_train_3388_passage", "type": "progene_text", "text": [ "The receptor encoded by GPR34 is most similar to the P2Y receptor subfamily , while the receptor encoded by GPR44 is most similar to chemoattractant receptors ." ], "offsets": [ [ 0, 160 ] ] } ]
[ { "id": "split_0_train_5492_entity", "type": "progene_text", "text": [ "GPR34" ], "offsets": [ [ 24, 29 ] ], "normalized": [] }, { "id": "split_0_train_5493_entity", "type": "progene_text", "text": [ "P2Y receptor subfamily" ], "offsets": [ [ 53, 75 ] ], "normalized": [] }, { "id": "split_0_train_5494_entity", "type": "progene_text", "text": [ "GPR44" ], "offsets": [ [ 108, 113 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3389
split_0_train_3389
[ { "id": "split_0_train_3389_passage", "type": "progene_text", "text": [ "The receptor encoded by GPR45 is the mammalian orthologue of a putative lysophosphatidic acid receptor from Xenopus laevis ." ], "offsets": [ [ 0, 124 ] ] } ]
[ { "id": "split_0_train_5495_entity", "type": "progene_text", "text": [ "GPR45" ], "offsets": [ [ 24, 29 ] ], "normalized": [] }, { "id": "split_0_train_5496_entity", "type": "progene_text", "text": [ "lysophosphatidic acid receptor" ], "offsets": [ [ 72, 102 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3390
split_0_train_3390
[ { "id": "split_0_train_3390_passage", "type": "progene_text", "text": [ "Partial sequence of GPR34 was discovered during a search of the GenBank database of expressed sequence tags ( ESTs ) ." ], "offsets": [ [ 0, 118 ] ] } ]
[ { "id": "split_0_train_5497_entity", "type": "progene_text", "text": [ "GPR34" ], "offsets": [ [ 20, 25 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3391
split_0_train_3391
[ { "id": "split_0_train_3391_passage", "type": "progene_text", "text": [ "This sequence information was used both to isolate the full - length translational open reading frame from a human genomic library and to assemble a contig from additional GPR34 EST cDNAs ." ], "offsets": [ [ 0, 189 ] ] } ]
[ { "id": "split_0_train_5498_entity", "type": "progene_text", "text": [ "GPR34" ], "offsets": [ [ 172, 177 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3392
split_0_train_3392
[ { "id": "split_0_train_3392_passage", "type": "progene_text", "text": [ "Northern blot and in situ hybridization analyses revealed GPR34 mRNA transcripts in several human and rat brain regions ." ], "offsets": [ [ 0, 121 ] ] } ]
[ { "id": "split_0_train_5499_entity", "type": "progene_text", "text": [ "GPR34" ], "offsets": [ [ 58, 63 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3393
split_0_train_3393
[ { "id": "split_0_train_3393_passage", "type": "progene_text", "text": [ "Also , we used polymerase chain reaction ( PCR ) to amplify human genomic DNA using degenerate oligonucleotides designed from sequences encoding transmembrane domains 3 and 7 of opioid and somatostatin receptors ." ], "offsets": [ [ 0, 213 ] ] } ]
[ { "id": "split_0_train_5500_entity", "type": "progene_text", "text": [ "opioid and somatostatin receptors" ], "offsets": [ [ 178, 211 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3394
split_0_train_3394
[ { "id": "split_0_train_3394_passage", "type": "progene_text", "text": [ "Two PCR products partially encoding novel GPCRs , named GPR44 and GPR45 , were discovered and used to isolate the full - length translational open reading frames from a human genomic library ." ], "offsets": [ [ 0, 192 ] ] } ]
[ { "id": "split_0_train_5501_entity", "type": "progene_text", "text": [ "GPCRs" ], "offsets": [ [ 42, 47 ] ], "normalized": [] }, { "id": "split_0_train_5502_entity", "type": "progene_text", "text": [ "GPR44" ], "offsets": [ [ 56, 61 ] ], "normalized": [] }, { "id": "split_0_train_5503_entity", "type": "progene_text", "text": [ "GPR45" ], "offsets": [ [ 66, 71 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3395
split_0_train_3395
[ { "id": "split_0_train_3395_passage", "type": "progene_text", "text": [ "Both GPR44 and GPR45 are expressed in the central nervous system and periphery ." ], "offsets": [ [ 0, 80 ] ] } ]
[ { "id": "split_0_train_5504_entity", "type": "progene_text", "text": [ "GPR44" ], "offsets": [ [ 5, 10 ] ], "normalized": [] }, { "id": "split_0_train_5505_entity", "type": "progene_text", "text": [ "GPR45" ], "offsets": [ [ 15, 20 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3396
split_0_train_3396
[ { "id": "split_0_train_3396_passage", "type": "progene_text", "text": [ "For chromosomal localization , fluorescence in situ hybridization analysis was performed to assign GPR34 to chromosomes 4p12 and Xp11 ." ], "offsets": [ [ 0, 135 ] ] } ]
[ { "id": "split_0_train_5506_entity", "type": "progene_text", "text": [ "GPR34" ], "offsets": [ [ 99, 104 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3397
split_0_train_3397
[ { "id": "split_0_train_3397_passage", "type": "progene_text", "text": [ "3 , GPR44 to chromosome 11q12 - q13.3 , and GPR45 to chromosome 2q11. 1-q12 ." ], "offsets": [ [ 0, 77 ] ] } ]
[ { "id": "split_0_train_5507_entity", "type": "progene_text", "text": [ "GPR44" ], "offsets": [ [ 4, 9 ] ], "normalized": [] }, { "id": "split_0_train_5508_entity", "type": "progene_text", "text": [ "GPR45" ], "offsets": [ [ 44, 49 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3398
split_0_train_3398
[ { "id": "split_0_train_3398_passage", "type": "progene_text", "text": [ "unr , a cellular cytoplasmic RNA - binding protein with five cold - shock domains , is required for internal initiation of translation of human rhinovirus RNA ." ], "offsets": [ [ 0, 160 ] ] } ]
[ { "id": "split_0_train_5509_entity", "type": "progene_text", "text": [ "unr" ], "offsets": [ [ 0, 3 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_3399
split_0_train_3399
[ { "id": "split_0_train_3399_passage", "type": "progene_text", "text": [ "Initiation of translation of the animal picornavirus RNAs occurs via a mechanism of direct ribosome entry , which requires a segment of the 5' UTR of the RNA , known as the internal ribosome entry site ( IRES ) ." ], "offsets": [ [ 0, 212 ] ] } ]
[]
[]
[]
[]